Lori Calabrese, MD
Lori Calabrese is Founder and Medical Director of Innovative Psychiatry, a private clinic offering novel psychiatric treatment for adults and adolescents and real-world transparent clinical research using innovative ketogenic intervention and ketamine therapies. Dr. Calabrese was educated at Wellesley College and The Johns Hopkins University School of Medicine and completed residency training through Harvard Medical School at Massachusetts General Hospital. She served for years as clinical faculty at both Harvard Medical School and Yale School of Medicine.
She and her team were the first to describe the use of a ketogenic diet in an innovative sequenced treatment that led to remission of severe chronic anorexia, and published a pilot trial supporting this -– an exciting and disruptive finding which has sparked global interest and a new single-group assignment clinical trial now investigating the use of a ketogenic diet for one of the deadliest disorders in psychiatry. She is a Clinical Advisor to Metabolic Mind/Baszucki Group, an invited speaker for Nutrition Network, and has presented her recent work in metabolic psychiatry at SMH San Diego/Society of Metabolic Health Practitioners, the International Neurological Ketogenic Society, and Metabolic Health Summit.
Dr. Calabrese just published the first case series of complete remission of major depression and anxiety using a ketogenic diet in adults with complex comorbidity. Her profound commitment to the best, most impactful treatments for her patients has culminated in Touchpoints 180 TM, a novel ketogenic program that aims to set a new standard for psychiatric care.
